{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:02:26Z","timestamp":1776297746059,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s12185-022-03528-0","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T11:05:55Z","timestamp":1673003155000},"page":"669-677","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["High levels of factor VIII activity in patients with acquired hemophilia A in remission are associated with unusually low coagulation potentials"],"prefix":"10.1007","volume":"117","author":[{"given":"Fumitaka","family":"Shibasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9348-9815","authenticated-orcid":false,"given":"Masahiro","family":"Takeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Ogiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naruto","family":"Shimonishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"issue":"Suppl 1","key":"3528_CR1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1538-7836.2011.04309.x","volume":"9","author":"PW Collins","year":"2011","unstructured":"Collins PW. Management of acquired haemophilia A. J Thromb Haemost. 2011;9(Suppl 1):226\u201335.","journal-title":"J Thromb Haemost"},{"key":"3528_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1046\/j.1365-2141.2003.04162.x","volume":"121","author":"J Delgado","year":"2003","unstructured":"Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol. 2003;121:21\u201335.","journal-title":"Br J Haematol"},{"key":"3528_CR3","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1160\/TH13-05-0363","volume":"110","author":"M Franchini","year":"2013","unstructured":"Franchini M, Mannucci PM. Acquired haemophilia A: a 2013 update. Thromb Haemost. 2013;110:1114\u201320.","journal-title":"Thromb Haemost"},{"key":"3528_CR4","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","volume":"109","author":"PW Collins","year":"2007","unstructured":"Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors\u2019 Organisation. Blood. 2007;109:1870\u20137.","journal-title":"Blood"},{"key":"3528_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1182\/blood-2008-03-143586","volume":"112","author":"M Franchini","year":"2008","unstructured":"Franchini M, Lippi G. Acquired factor VIII inhibitors. Blood. 2008;112:250\u20135.","journal-title":"Blood"},{"key":"3528_CR6","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1538-7836.2012.04654.x","volume":"10","author":"P Knoebl","year":"2012","unstructured":"Knoebl P, Marco P, Baudo F, Collins P, Huth-Kuhne A, Nemes L, et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost. 2012;10:622\u201331.","journal-title":"J Thromb Haemost"},{"key":"3528_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000071636","volume":"33","author":"HC Hemker","year":"2003","unstructured":"Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb. 2003;33:4\u201315.","journal-title":"Pathophysiol Haemost Thromb"},{"key":"3528_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000071637","volume":"33","author":"PL Turecek","year":"2003","unstructured":"Turecek PL, Varadi K, Keil B, Negrier C, Berntorp E, Astermark J, et al. Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay. Pathophysiol Haemost Thromb. 2003;33:16\u201322.","journal-title":"Pathophysiol Haemost Thromb"},{"key":"3528_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12185-017-2273-6","volume":"107","author":"M Takeyama","year":"2018","unstructured":"Takeyama M, Nogami K, Kajimoto T, Ogiwara K, Matsumoto T, Shima M. First report of real-time monitoring of coagulation function potential and IgG subtype of anti-FVIII autoantibodies in a child with acquired hemophilia A associated with streptococcal infection and amoxicillin. Int J Hematol. 2018;107:112\u20136.","journal-title":"Int J Hematol"},{"key":"3528_CR10","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1111\/hae.13134","volume":"23","author":"M Takeyama","year":"2017","unstructured":"Takeyama M, Nogami K, Matsumoto T, Taguchi M, Yada K, Okahashi N, et al. Possible assessment of coagulation function and haemostasis therapy using comprehensive coagulation assays in a patient with acquired haemophilia A. Haemophilia. 2017;23:e46\u201350.","journal-title":"Haemophilia"},{"key":"3528_CR11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1160\/TH13-04-0345","volume":"110","author":"T Matsumoto","year":"2013","unstructured":"Matsumoto T, Nogami K, Shima M. Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis. Thromb Haemost. 2013;110:761\u20138.","journal-title":"Thromb Haemost"},{"key":"3528_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12185-021-03249-w","volume":"115","author":"M Takeyama","year":"2022","unstructured":"Takeyama M, Sasai K, Matsumoto T, Furukawa S, Ogiwara K, Yada K, et al. Comprehensive blood coagulation potential in patients with acquired hemophilia A: retrospective analyses of plasma samples obtained from nationwide centers across Japan. Int J Hematol. 2022;115:163\u201372.","journal-title":"Int J Hematol"},{"key":"3528_CR13","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1055\/s-0041-1725009","volume":"121","author":"M Takeyama","year":"2021","unstructured":"Takeyama M, Furukawa S, Yada K, Ogiwara K, Shimonishi N, Nakajima Y, et al. Ex vivo prediction of comprehensive coagulation potential using simulated blood concentrations of emicizumab in patients with acquired hemophilia A. Thromb Haemost. 2021;121:1289\u201398.","journal-title":"Thromb Haemost"},{"key":"3528_CR14","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s12185-020-02823-y","volume":"111","author":"Y Ogawa","year":"2020","unstructured":"Ogawa Y, Yanagisawa K, Naito C, Uchiumi H, Ishizaki T, Shimizu H, et al. Overshoot of FVIII activity in patients with acquired hemophilia A who achieve complete remission. Int J Hematol. 2020;111:544\u20139.","journal-title":"Int J Hematol"},{"key":"3528_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1365-2141.2012.09134.x","volume":"157","author":"PV Jenkins","year":"2012","unstructured":"Jenkins PV, Rawley O, Smith OP, O\u2019Donnell JS. Elevated factor VIII levels and risk of venous thrombosis. Br J Haematol. 2012;157:653\u201363.","journal-title":"Br J Haematol"},{"key":"3528_CR16","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1021\/bi00507a028","volume":"20","author":"LT Mimms","year":"1981","unstructured":"Mimms LT, Zampighi G, Nozaki Y, Tanford C, Reynolds JA. Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside. Biochemistry. 1981;20:833\u201340.","journal-title":"Biochemistry"},{"key":"3528_CR17","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1055\/s-0037-1614572","volume":"81","author":"M Shibata","year":"1999","unstructured":"Shibata M, Shima M, Fujimura Y, Takahashi Y, Nakai H, Sakurai Y, et al. Identification of the binding site for an alloantibody to von Willebrand factor which inhibits binding to glycoprotein Ib within the amino-terminal region flanking the A1 domain. Thromb Haemost. 1999;81:793\u20138.","journal-title":"Thromb Haemost"},{"key":"3528_CR18","first-page":"612","volume":"34","author":"CK Kasper","year":"1975","unstructured":"Kasper CK, Aledort L, Aronson D, Counts R, Edson JR, van Eys J, et al. Proceedings: a more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh. 1975;34:612.","journal-title":"Thromb Diath Haemorrh"},{"key":"3528_CR19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s12185-009-0450-y","volume":"90","author":"T Matsumoto","year":"2009","unstructured":"Matsumoto T, Nogami K, Ogiwara K, Shima M. A modified thrombin generation test for investigating very low levels of factor VIII activity in hemophilia A. Int J Hematol. 2009;90:576\u201382.","journal-title":"Int J Hematol"},{"key":"3528_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/bjh.14148","volume":"174","author":"K Nogami","year":"2016","unstructured":"Nogami K. The utility of thromboelastography in inherited and acquired bleeding disorders. Br J Haematol. 2016;174:503\u201314.","journal-title":"Br J Haematol"},{"key":"3528_CR21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12185-019-02698-8","volume":"110","author":"K Yada","year":"2019","unstructured":"Yada K, Nogami K, Ogiwara K, Shida Y, Furukawa S, Yaoi H, et al. Global coagulation function assessed by rotational thromboelastometry predicts coagulation-steady state in individual hemophilia A patients receiving emicizumab prophylaxis. Int J Hematol. 2019;110:419\u201330.","journal-title":"Int J Hematol"},{"key":"3528_CR22","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1055\/s-0038-1649638","volume":"70","author":"HC Hemker","year":"1993","unstructured":"Hemker HC, Wielders S, Kessels H, Beguin S. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost. 1993;70:617\u201324.","journal-title":"Thromb Haemost"},{"key":"3528_CR23","doi-asserted-by":"publisher","first-page":"21948","DOI":"10.1016\/S0021-9258(18)54729-3","volume":"266","author":"RJ Wise","year":"1991","unstructured":"Wise RJ, Dorner AJ, Krane M, Pittman DD, Kaufman RJ. The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII. J Biol Chem. 1991;266:21948\u201355.","journal-title":"J Biol Chem"},{"key":"3528_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-0037-1615834","volume":"82","author":"RJ Kaufman","year":"1999","unstructured":"Kaufman RJ, Pipe SW. Regulation of factor VIII expression and activity by von Willebrand factor. Thromb Haemost. 1999;82:201\u20138.","journal-title":"Thromb Haemost"},{"key":"3528_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2516.2009.02005.x","volume":"16","author":"V Terraube","year":"2010","unstructured":"Terraube V, O\u2019Donnell JS, Jenkins PV. Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance. Haemophilia. 2010;16:3\u201313.","journal-title":"Haemophilia"},{"key":"3528_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1160\/TH05-07-0527","volume":"95","author":"AD Blann","year":"2006","unstructured":"Blann AD. Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years. Thromb Haemost. 2006;95:49\u201355.","journal-title":"Thromb Haemost"},{"key":"3528_CR27","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0022-5223(99)70066-8","volume":"118","author":"P Borgdorff","year":"1999","unstructured":"Borgdorff P, van den Berg RH, Vis MA, van den Bos GC, Tangelder GJ. Pump-induced platelet aggregation in albumin-coated extracorporeal systems. J Thorac Cardiovasc Surg. 1999;118:946\u201352.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"Suppl 1","key":"3528_CR28","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1002\/ajh.23142","volume":"87","author":"PD James","year":"2012","unstructured":"James PD, Lillicrap D. von Willebrand disease: clinical and laboratory lessons learned from the large von Willebrand disease studies. Am J Hematol. 2012;87(Suppl 1):S4-11.","journal-title":"Am J Hematol"},{"key":"3528_CR29","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1056\/NEJM200008173430702","volume":"343","author":"PA Kyrle","year":"2000","unstructured":"Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med. 2000;343:457\u201362.","journal-title":"N Engl J Med"},{"key":"3528_CR30","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1046\/j.1365-2141.2003.04795.x","volume":"124","author":"L Cristina","year":"2004","unstructured":"Cristina L, Benilde C, Michela C, Mirella F, Giuliana G, Gualtiero P. High plasma levels of factor VIII and risk of recurrence of venous thromboembolism. Br J Haematol. 2004;124:504\u201310.","journal-title":"Br J Haematol"},{"key":"3528_CR31","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/S0002-9343(02)01345-1","volume":"113","author":"AW Tsai","year":"2002","unstructured":"Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Tracy RP, Aleksic N, et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med. 2002;113:636\u201342.","journal-title":"Am J Med"},{"key":"3528_CR32","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s12288-019-01092-y","volume":"35","author":"S Rajpal","year":"2019","unstructured":"Rajpal S, Ahluwalia J, Kumar N, Malhotra P, Uppal V. Elevated Von Willebrand factor antigen levels are an independent risk factor for venous thromboembolism: first report from North India. Indian J Hematol Blood Transfus. 2019;35:489\u201395.","journal-title":"Indian J Hematol Blood Transfus"},{"key":"3528_CR33","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1160\/TH09-03-0180","volume":"102","author":"KR Machlus","year":"2009","unstructured":"Machlus KR, Colby EA, Wu JR, Koch GG, Key NS, Wolberg AS. Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram. Thromb Haemost. 2009;102:936\u201344.","journal-title":"Thromb Haemost"},{"key":"3528_CR34","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.thromres.2011.07.020","volume":"129","author":"JK Ryland","year":"2012","unstructured":"Ryland JK, Lawrie AS, Mackie IJ, Machin SJ. Persistent high factor VIII activity leading to increased thrombin generation\u2014a prospective cohort study. Thromb Res. 2012;129:447\u201352.","journal-title":"Thromb Res"},{"key":"3528_CR35","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1159\/000189118","volume":"73","author":"IC Haznedaro\u011flu","year":"1996","unstructured":"Haznedaro\u011flu IC, Erdem Y, Yalcin AU, Sayinalp NM, Yasavul U, Turgan C, et al. Circulating thrombomodulin as a molecular marker of endothelium damage in renal transplant recipients. Nephron. 1996;73:486\u20137.","journal-title":"Nephron"},{"key":"3528_CR36","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1182\/blood.V76.10.2024.2024","volume":"76","author":"S Takano","year":"1990","unstructured":"Takano S, Kimura S, Ohdama S, Aoki N. Plasma thrombomodulin in health and diseases. Blood. 1990;76:2024\u20139.","journal-title":"Blood"},{"key":"3528_CR37","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1096\/fasebj.6.8.1317308","volume":"6","author":"FJ Walker","year":"1992","unstructured":"Walker FJ, Fay PJ. Regulation of blood coagulation by the protein C system. FASEB J. 1992;6:2561\u20137.","journal-title":"FASEB J"},{"key":"3528_CR38","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/00001721-199611000-00003","volume":"7","author":"MA Laffan","year":"1996","unstructured":"Laffan MA, Manning R. The influence of factor VIII on measurement of activated protein C resistance. Blood Coagul Fibrinolysis. 1996;7:761\u20135.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"3528_CR39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/MOH.0000000000000726","volume":"29","author":"G Leon","year":"2022","unstructured":"Leon G, Rehill AM, Preston RJS. The protein C pathways. Curr Opin Hematol. 2022;29:251\u20138.","journal-title":"Curr Opin Hematol"},{"key":"3528_CR40","doi-asserted-by":"publisher","first-page":"6685","DOI":"10.1182\/blood-2010-11-317099","volume":"117","author":"J Ahnstr\u00f6m","year":"2011","unstructured":"Ahnstr\u00f6m J, Andersson HM, Canis K, Norstr\u00f8m E, Yu Y, Dahlb\u00e4ck B, et al. Activated protein C cofactor function of protein S: a novel role for a \u03b3-carboxyglutamic acid residue. Blood. 2011;117:6685\u201393.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03528-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-022-03528-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03528-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T13:22:19Z","timestamp":1682083339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-022-03528-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["3528"],"URL":"https:\/\/doi.org\/10.1007\/s12185-022-03528-0","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,6]]},"assertion":[{"value":"19 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors stated that they had no interests which might be perceived as posing a conflict or bias.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Medical Research Ethics Committee of the Nara Medical University (No. 2503).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Blood samples and clinical data were obtained from the patients after informed consent or web-site opt-out. In addition, reference blood samples were obtained from normal healthy individuals after informed consent at the Nara Medical University hospital, following the local ethical guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}